Ester Industries Ltd
Q2 FY23 Earnings Call Analysis
Industrial Products
fundraise: No informationcapex: Yesrevenue: Category 4margin: Category 3orderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- No explicit mention of any new fundraising through debt or equity during the call.
- Current total debt is approximately Rs. 650 crore, with a repayment schedule of Rs. 100 crore in the current year (Rs. 52 crore already repaid).
- Telangana facility loan had a moratorium which is now over; repayments have commenced from June 30, 2023.
- Management did not indicate plans for fresh borrowings or equity issuance.
- Focus remains on managing current debt and improving utilization and profitability before any new fundraising is considered.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- The Telangana plant, commissioned in January, is currently in the ramp-up/stabilization phase; full capacity utilization is expected by the end of the year.
- The company has invested in an off-line coater aimed at increasing the share of value-added products, which is expected to be commissioned soon.
- No specific mention of other current or future capital expenditure or strategic investment in the transcript.
- The focus appears to be on improving capacity utilization at existing plants (Telangana and Filmtech), enhancing product mix, and leveraging R&D for new, profitable products.
- Debt repayment schedules include amounts associated with Telangana plant funding, indicating recent capital investments but no new announced capex.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Revenue target for next 2 years: Difficult to specify exact numbers currently; expected to be in line with past performance, dependent on product realization and raw material costs (Sourabh Agarwal).
- Specialty Polymers: Recovery anticipated post-US recession; current low offtake expected to improve over the medium to long term (Sourabh Agarwal).
- Telangana plant: Under ramp-up with expected full capacity utilization by end of the year, poised to generate approx. 48,000 tons at full scale (Girish Behal & Sourabh Agarwal).
- Ester Filmtech volumes: Growing gradually; Q1FY24 volume at 5,760 MT, expected to improve with stabilization (Sourabh Agarwal).
- Film business: Anticipated marginal improvement in volumes in Q2FY24 over Q1, dependent on market conditions (Sourabh Agarwal).
- Focus on increasing value-added product share (currently ~28%) to improve profitability and product mix.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Near-term outlook remains challenging due to excess supply in films business and recessionary concerns in the US impacting Specialty Polymers.
- Management optimistic about medium to long-term growth, expecting recovery in demand, especially in Specialty Polymers as US economy improves.
- Specialty Polymers sales expected to revive after slow quarters; focus on leveraging R&D and launching new products.
- Film business margins under pressure but efforts underway to improve product mix by increasing value-added products (targeting 28-30% value-added mix).
- Telangana plant ramp-up to full capacity expected by end of current year, contributing positively to volumes and revenues.
- Overall revenue growth dependent on market conditions, raw material costs, and product realizations; no specific revenue targets provided.
- EBITDA and profitability expected to improve as utilization and market conditions normalize, with stable, profitable performance targeted long-term.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
The transcript does not provide specific details regarding the current or expected order book or pending orders for Ester Industries Limited. Key insights related to business outlook and capacity utilization include:
- Telangana plant is in ramp-up phase, expected to reach full capacity by end of FY24.
- Film business faces subdued demand and excess supply, impacting realizations.
- Specialty Polymer business affected by recessionary worries in the US market.
- The company remains optimistic about medium to long-term recovery and growth.
- New product developments and value-added product mix enhancement are underway.
- No explicit figures or commentary on current order book or pending orders mentioned.
Hence, no concrete data on order book or pending orders is disclosed in this earnings call transcript.
